- Home
- JG vs ATRA Comparison
JG vs ATRA Comparison
Compare JG & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JG | ATRA |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.6M | 37.6M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | JG | ATRA |
|---|---|---|
| Price | $7.66 | $5.56 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 7.6K | ★ 700.7K |
| Earning Date | 03-12-2026 | 03-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.97 |
| Revenue | $50,967,244.00 | ★ $151,930,000.00 |
| Revenue This Year | $10.90 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.69 |
| Revenue Growth | 20.78 | ★ 51.27 |
| 52 Week Low | $5.85 | $4.20 |
| 52 Week High | $20.94 | $19.15 |
Technical Indicators
Market Signals| Indicator | JG | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 56.74 | 30.58 |
| Support Level | $6.71 | $4.20 |
| Resistance Level | $8.10 | $5.19 |
| Average True Range (ATR) | 0.56 | 1.15 |
| MACD | 0.06 | -0.36 |
| Stochastic Oscillator | 58.89 | 10.30 |
Price Performance
Historical ComparisonAbout JG Aurora Mobile Limited
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).